Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Hepatology. 2021 Aug 26;74(6):2952–2964. doi: 10.1002/hep.32053

FIG. 1.

FIG. 1.

Consort diagram–PRIORITIZE study flowchart. 1Randomization Failures. 2Includes ALL EBR.GZR & LDV/SOF Patients from Phase 1. 3Includes 1 PrOD patient treated with LDV/SOF. Abbreviations: EBR/GZR, elbasvir/grazoprevir; LDV/SOF, ledipasvir/sofosbuvir; PrOD, paritaprevir/ritonavir/ombitasvir+dasabuvir.